Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Business Overview and Strategy
TECH logo

Bio-Techne Net Sales Rise 2% to $1.159 Billion Amid Acquisition Growth

TECH10-KFiling Date: 8/22/2024
Bio-Techne Corporation
Description

What this story covers

Bio-Techne's fiscal 2024 10-K reports 2 percent net sales growth to 1 point 159 billion dollars, driven by Diagnostics and Genomics gains and Lunaphore acquisition, despite Protein Sciences headwinds. Adjusted EPS 1 dollar 77 cents, solid liquidity with 299 million dollars operating cash flow, but faces economic, regulatory, and integration risks.

Story snapshot

CompanyBio-Techne Corporation
TickerTECH
VariantStandard detailed
Duration21:16
Filing type10-K
PeriodAnnual 2024
IndustryHealthcare & Pharmaceuticals
Accession0001558370-24-012430

Full Story Script

Content not available for this story.

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in